About this trial
This clinical trial is studying the genetic changes in cells associated with different types of cancer in American Indian (AI) populations in the Southwest to improve cancer screening, precision prevention, and therapeutic intervention for individual in these communities. AI tribes have much lower rates of cancer screening, have more limited access to healthcare, are more often diagnosed at later stages of disease, and have the poorest outcomes in all types of cancer when compared to any other racial and ethnic group in the United States. Due to these significant cancer health disparities, AIs have been understudied and little is known about the molecular characterization of tumors arising in AIs. Undergoing genetic testing of tumors may improve cancer outcomes in AI participants and communities.
Eligibility criteria
Qualifiers
Male or female adults >= 18 years of age
Cancer patient undergoing active treatment or a cancer survivor
Self-identify as American Indian
Disqualifiers
Unable to provide informed consent
Individuals who are under 18 years of age
Prisoners
Trial design
Treatments tested in this trial
- Biospecimen Collection
- Communication Intervention
- Genetic Testing
- Survey Administration
Treatment groups
Sponsors and collaborators
Mayo Clinic
Lead sponsor
National Cancer Institute (NCI)
Collaborator